Opioids Prescribed For Cancer Patients Could Soon Be Replaced

Cancer patients are prescribed with opioids for chronic pain and it carries the risk of addiction and side effects. A breakthrough finding offers a hope to replace the use of opioids. //

The discovery of a new biological pathway involved in pain processing offers hope of using existing cancer drugs to replace the use of opioids in chronic pain treatment according to a study done by Luda Diatchenko, professor at McGill's Faculty of Dentistry and co-lead author of the new study.

Prescription Drug Abuse
Prescription drug abuse is consuming prescription medications in a way different from that as prescribed by the doctor. It is becoming a colossal health problem which can lead to addiction and even death.

‘Epidermal growth factor receptor (EGFR) blockers, routinely given to lung cancer patients to inhibit tumor growth, were as potent analgesics as morphine in mouse models of inflammatory and chronic pain.’

Tweet it Now

The scientists discovered that EGFR blockers, routinely given to lung cancer patients to inhibit tumour growth, were as potent analgesics as morphine in mouse models of inflammatory and chronic pain.

"We now need to answer two questions: Is this really effective for human chronic pain? And what are the side effects associated with the dosage needed to efficiently treat it?" says Diatchenko, who holds the Canada Excellence Research Chair in Human Pain Genetics.

Repurposing existing drugs to treat diseases other than those they were designed for can be advantageous, because the toxicity of these compounds is well understood, making them a fast and relatively inexpensive way to develop new treatments.

Cancer Pain - Causes - Effects - Assessment - Treatment - FAQs - Video
Every 1 out of 3 people undergoing cancer treatment experiences pain.

If these cancer therapeutics don't turn out to be useful for pain management, they could nevertheless be used as the foundation to develop new drugs.

"By re-engineering or tweaking these drugs, the road to getting to a useful pain treatment will be much, much shorter," explains Jeffrey Mogil, professor at McGill's Department of Psychology and the study's co-lead author.

How to Cope with Cancer Pain - Caues, Types & Treatment
Pain occurs in about 20-50% of patients with cancer. Proper therapeutic approach can help relieve and manage the condition.

The research, published in The Journal of Clinical Investigation, describes the crucial role in pain of a protein known as epidermal growth factor receptor (EGFR).

"This is quite exciting as EGFR is one of the most studied proteins in all of biomedicine because of its important role in cancer. But aside from a few clinical case studies, a role for EGFR in pain has never been shown", adds Mogil, who is also the director of the Alan Edwards Centre for Research on Pain.

Cancer Pain - A Menacing Condition
Pain is a common complaint and a frequent symptom in the cancer patients,affecting one third of the cancer cases.Pain can be due to cancer itself,cancer treatments or co-morbidities related to cancer.

The researchers believe the EGFR pain pathway they found in mice and fruit flies is relevant to humans because of genetic results also reported in the paper on human cohorts with chronic facial pain, which linked two genes in the EGFR pathway.

"We know this pathway is relevant in humans," Diatchenko says. "This discovery is very exciting and important; it's really going to help us extend our knowledge about the molecular pathophysiology of chronic pain."

The scientists hope their findings will lead to clinical trials in order to assess the potential of EGFR inhibitors used in cancer therapy as pain management therapeutics.

Source-Eurekalert